Related Experiment Video
Updated: Sep 1, 2025

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Recurrent vulvovaginal candidiasis with Candida glabrata - a management conundrum
Neda Taghinejadi1,2, Monique I Andersson3,4, Emily Lord1
1Department of Sexual Health, 6397Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Abstract:
High rates of azole-resistance and limited availability of pharmacological agents within the UK can make recurrent vulvovaginal candidiasis (RVVC) with Candida glabrata a challenging infection to treat. In this report, we describe our experience in managing C. glabrata RVVC and present the case of a patient with poor response to therapy and a protracted treatment course, spanning almost 4 years. We also highlight the need for evidence-based management protocols that consider the national availability of alternative treatments.
More Related Videos
07:57Protocols for Vaginal Inoculation and Sample Collection in the Experimental Mouse Model of Candida vaginitis
Published on: December 8, 2011
09:06Author Spotlight: Photodynamic Therapy as a Novel Approach to Induce Petite Colonies in Drug-Resistant Candida for Antifungal Research
Published on: March 29, 2024
Related Concept Videos
Urinary Tract Infection IV: Nursing Management
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Endocarditis III: Medical Management
Cystic Fibrosis: Management
Sinus disease and chronic...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care